Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/
 Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Teva Pharmaceutical Industries Ltd (TEVA)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
3,683 +66    +1.82%
10:24:50 - Closed. Currency in ILS ( Disclaimer )
Type:  Equity
Market:  Israel
ISIN:  IL0006290147 
S/N:  629014
  • Volume: 3,342,999
  • Bid/Ask: 3,683 / 3,686
  • Day's Range: 3,516 - 3,688
Teva 3,683 +66 +1.82%

Teva Pharmaceutical Industries Ltd Company Profile

 
Get an in-depth profile of Teva Pharmaceutical Industries Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

35346

Equity Type

ORD

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company’s products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Contact Information

Address 124 Dvora Hanevi’a Street
Tel Aviv, 6944020
Israel
Phone 972 3 914 8213
Fax -
Web www.tevapharm.com

Top Executives

Name Age Since Title
Amir Elstein 66 2005 Independent Director
Sol J. Barer 75 2015 Independent Chairman of the Board
Jean-Michel Halfon 70 2014 Independent Director
Kare Schultz 61 2017 President, CEO & Director
Rosemary A. Crane 62 2015 Independent Director
Ronit Satchi-Fainaro 50 2018 Independent Director
Janet S. Vergis 58 2020 Independent Director
Gerald M. Lieberman 75 2015 Independent Director
Perry D. Nisen 66 2017 Independent Director
Roberto Agostino Mignone 50 2017 Independent Director
Nechemia J. Peres 63 2017 Independent Director
Tal Zaks 56 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

TEVA Comments

Write your thoughts about Teva Pharmaceutical Industries Ltd
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ramba Łej
Kubizm Jun 02, 2022 3:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
while teva is within channel and have been moving horizontally, riseing volume is worth noticing. I think we are in well-advanced accumulation state. I hope teva will solve opioid bs and find its way to increase sales volume
Reply
1 0
Report
Michael Shalom
Michael Shalom Nov 25, 2021 3:27AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
asdfasdfadf investing
Reply
0 0
Report
Michael Shalom
Michael Shalom Nov 24, 2021 7:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
google <a href="https://www.google.com"> google </a>
Reply
1 0
Report
TSahi Livnoni
TSahi Livnoni Oct 18, 2020 3:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
nice move against nasdaq on last friday
Reply
0 0
Report
SS SS
SS SS Apr 13, 2020 2:55AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hello Associates & Partners I sold at 10.45 $ and now I am looking to entry in NGM , MYOVANT or MERSANA what which is your impact and your opinion which equity will go better for short term? please if anybody knows let me know your precious feedback, Szilike.
Reply
0 0
Report
Playing Best
Playing Best Mar 31, 2020 5:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
good news. teva will sell malaria cure against the corrona virus
Reply
1 1
Report
Sam Diamond
Sam Diamond Mar 31, 2020 5:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I personally know someone who used it and it worked very well. They are going to see some big volumes even if they have competition. When you're dealing with these quantities, everyone makes money.
Reply
0 1
Report
test test
test test Mar 31, 2020 5:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Yes
Reply
1 0
Report
test test
test test Mar 31, 2020 5:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
test test ok
Reply
1 0
Report
Vladi Pukin
Vladi Pukin Mar 31, 2020 5:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Sam Diamond agree
Reply
0 0
Report
Sam Diamond
Sam Diamond Mar 22, 2020 5:27AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
when the Dow drops 900 points and Teva is up, that's a really good sign of strength.
Reply
1 0
Report
Oron Matzri
Oron Matzri Mar 17, 2020 11:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
buy?
Reply
1 0
Report
Sam Diamond
Sam Diamond Mar 17, 2020 11:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Yep, they have the main drug to treat the plague, and they are already restructured and doing well.
Reply
1 0
Report
Oron Matzri
Oron Matzri Mar 17, 2020 11:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
buy?
Reply
0 0
Report
eyal isaac
eyal isaac Sep 02, 2019 9:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
after 3 long hard years, TEVA is finally found the bottom.. better years ahead for the company and the stock. this will be one mighty comeback! "a wounded lion is still a lion"...
Reply
4 0
Report
Simon Stauber
Simon Stauber Sep 02, 2019 9:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
even if he offeres the lioness a ***
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email